Global Normothermic Organ Perfusion Systems for Transplantation Supply, Demand and Key Producers, 2026-2032
The global Normothermic Organ Perfusion Systems for Transplantation market size is expected to reach $ 1489 million by 2032, rising at a market growth of 15.1% CAGR during the forecast period (2026-2032).
Normothermic Organ Perfusion Systems for Transplantation are medical device platforms designed to preserve, assess and support donor organs outside the body under near-physiological temperature conditions, generally around 35–37°C. Unlike static cold storage, these systems maintain active circulation and oxygenation and can provide nutrients, temperature control and real-time physiological monitoring, enabling donor organs to remain metabolically active during preservation and evaluation. Commercial systems typically consist of a reusable perfusion console, pumping and oxygenation modules, temperature-control and monitoring units, organ-specific chambers and single-use perfusion circuits, with dedicated perfusates and other consumables forming an important recurring-revenue component. Current commercial applications are concentrated in liver, heart, lung and kidney transplantation, with deployment models ranging from center-based perfusion to transport-enabled platforms that can maintain active perfusion between donor recovery and recipient implantation. The market is primarily driven by the need to extend preservation windows, improve organ viability assessment, increase utilization of donation after circulatory death and marginal donor organs, and reduce the constraints associated with ischemic injury.
A second trend is the integration of perfusion technology with procurement and transportation infrastructure. Portable systems reduce the dependence of transplant activity on conventional cold ischemic time and make longer-distance organ recovery more practical. In Europe, investments announced in 2025–2026 indicate that integrated transplantation networks combining perfusion, clinical teams and dedicated ground and air logistics are moving beyond the U.S. model. Product development is also expanding toward kidney perfusion, greater automation and remote monitoring, which could broaden NMP from relatively concentrated liver, heart and lung use toward much larger transplant populations over the longer term.
The midstream consists of specialized organ perfusion system manufacturers responsible for system integration, regulatory approval, clinical validation, disposable manufacturing and technical support. Downstream users include transplant centers and hospitals, organ procurement and recovery organizations and, to a smaller extent, academic and research institutions. The increasing integration of organ recovery, perfusion management and logistics is making the boundary between medical-device manufacturing and transplant services more complex, although product revenue remains principally driven by installed platforms and procedure-linked consumables.
The highest-value platforms combine hardware, organ-specific consumables, software, clinical workflow support and logistics compatibility. Consequently, competitive advantage tends to strengthen as installed base and procedure volumes expand: more procedures create clinical data, support physician familiarity and increase recurring consumable demand. This creates relatively high switching barriers once a transplant center has established protocols, training and reimbursement processes around a particular platform.
By application, Organ Preservation & Transplant Preparation remains the largest category. Organ Viability Assessment is increasingly embedded into NMP workflows, particularly for organs with uncertain quality. Marginal Donor Organ Recovery is a smaller but strategically important growth segment because the commercial value of NMP increasingly depends on converting previously declined organs into transplantable grafts. Other applications include research, therapeutic conditioning and emerging organ-repair approaches, but these remain less commercialized.
Longer term, the opportunity extends beyond preservation alone. Continuous physiological data generated during NMP may support more standardized organ acceptance decisions, treatment of donor organs outside the body and eventually data-driven or algorithm-assisted viability assessment. These capabilities could increase the value of perfusion platforms even without equivalent growth in the number of donor organs.
Europe represents the second major technology and commercialization cluster, with established capabilities in liver, lung and abdominal organ perfusion and a growing emphasis on integrated logistics. Asia Pacific remains comparatively early in commercial adoption but presents meaningful long-term potential because of large populations, expanding transplant capabilities and increasing domestic medical-device development. China has begun developing indigenous NMP equipment, although commercial scale and installed base remain considerably below those of North America and Europe.
Regional competition is structurally differentiated. North America has the deepest commercialization and integrated service infrastructure, Europe has a broader base of specialized organ preservation technologies and strong liver and lung perfusion expertise, while China is emerging from clinical translation toward domestic commercialization. Consolidation is also becoming more important: strategic acquisitions are allowing larger medical-device groups to enter organ preservation technology while providing specialized perfusion businesses with manufacturing scale, regulatory resources and international distribution. The result is likely to remain a relatively concentrated global supplier base even as procedure volumes and geographic adoption expand.
This report is a detailed and comprehensive analysis of the world market for Normothermic Organ Perfusion Systems for Transplantation and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Normothermic Organ Perfusion Systems for Transplantation that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Normothermic Organ Perfusion Systems for Transplantation market
2. What is the demand of the global Normothermic Organ Perfusion Systems for Transplantation market?
3. What is the year over year growth of the global Normothermic Organ Perfusion Systems for Transplantation market?
4. What is the total value of the global Normothermic Organ Perfusion Systems for Transplantation market?
5. Who are the Major Players in the global Normothermic Organ Perfusion Systems for Transplantation market?
6. What are the growth factors driving the market demand?
Normothermic Organ Perfusion Systems for Transplantation are medical device platforms designed to preserve, assess and support donor organs outside the body under near-physiological temperature conditions, generally around 35–37°C. Unlike static cold storage, these systems maintain active circulation and oxygenation and can provide nutrients, temperature control and real-time physiological monitoring, enabling donor organs to remain metabolically active during preservation and evaluation. Commercial systems typically consist of a reusable perfusion console, pumping and oxygenation modules, temperature-control and monitoring units, organ-specific chambers and single-use perfusion circuits, with dedicated perfusates and other consumables forming an important recurring-revenue component. Current commercial applications are concentrated in liver, heart, lung and kidney transplantation, with deployment models ranging from center-based perfusion to transport-enabled platforms that can maintain active perfusion between donor recovery and recipient implantation. The market is primarily driven by the need to extend preservation windows, improve organ viability assessment, increase utilization of donation after circulatory death and marginal donor organs, and reduce the constraints associated with ischemic injury.
Key Findings
- In 2025, the average selling price of commercial normothermic organ perfusion systems worldwide was approximately US$150,000–250,000 per unit.
- The industry’s overall gross margin remained at approximately 55%–70% in 2025.
- Liver normothermic perfusion remained the largest commercial organ segment.
- North America remained the largest value market globally.
- Organ preservation and transplant preparation remained the largest application segment.
Market Trends
The principal technology trend is the transition from passive preservation toward active organ management. Normothermic perfusion maintains donor organs in a functioning or near-functioning physiological state and creates a time window in which clinicians can observe hemodynamic, metabolic and organ-specific parameters before implantation. This is changing the role of preservation technology from simple time extension to a broader combination of preservation, functional assessment and potentially therapeutic intervention. The commercial direction is also shifting toward organ-specific protocols built on common platform architectures, enabling manufacturers to leverage pumps, monitoring, temperature control, software and disposable technologies across multiple transplant indications.A second trend is the integration of perfusion technology with procurement and transportation infrastructure. Portable systems reduce the dependence of transplant activity on conventional cold ischemic time and make longer-distance organ recovery more practical. In Europe, investments announced in 2025–2026 indicate that integrated transplantation networks combining perfusion, clinical teams and dedicated ground and air logistics are moving beyond the U.S. model. Product development is also expanding toward kidney perfusion, greater automation and remote monitoring, which could broaden NMP from relatively concentrated liver, heart and lung use toward much larger transplant populations over the longer term.
Market Dynamics
Drivers
The central market driver is the persistent shortage of transplantable donor organs. U.S. transplant activity reached 46,750 solid-organ procedures in 2024, while 167,230 unique patients were present on transplant waiting lists during the year. At the same time, a meaningful proportion of recovered organs remain unused, including 29.3% of recovered kidneys and 11.3% of recovered lungs in 2024. Technologies that can provide functional assessment and improve confidence in marginal or DCD organs therefore have a direct clinical and economic rationale.Restraints
High equipment and procedure-related costs remain the principal restraint. Commercial NMP requires not only a perfusion console but also organ-specific disposable sets, perfusion solutions, trained personnel and workflow integration. Adoption is consequently concentrated in high-volume transplant centers and healthcare systems capable of supporting specialized operating procedures and reimbursement requirements. Clinical evidence and regulatory approvals are also organ-specific, limiting the ability of manufacturers to transfer commercial success from one organ indication directly to another.Opportunities
The largest structural opportunity lies in increasing utilization of organs that would otherwise be declined. DCD transplantation, extended-criteria donors, longer-distance donor recovery and objective viability assessment all enlarge the addressable procedure pool without requiring a proportional increase in donor availability. Kidney transplantation represents an especially significant longer-term opportunity because kidney transplant volumes are substantially larger than liver, heart or lung volumes, while current commercial NMP penetration remains limited. Next-generation platforms incorporating automation, continuous data collection and remote monitoring could also reduce operating complexity and extend the technology beyond a relatively small group of specialist centers.Challenges
The industry must demonstrate that higher preservation costs translate into improved organ utilization, clinical outcomes or transplant-center productivity. Evidence requirements are substantial because performance must be established separately across organs, donor populations and clinical protocols. Operational reliability is also critical: the equipment supports viable donor organs during time-sensitive transplantation processes, so pump failure, temperature instability, disposable-set problems or logistical interruptions can carry unusually high consequences. Scaling manufacturing and clinical-support capacity while maintaining quality systems is therefore a major barrier for emerging suppliers.Industry Chain Analysis
The upstream industry includes medical-grade pumps, oxygenators, heat exchangers, pressure and flow sensors, temperature-control components, sterile tubing, organ chambers, electronic control systems, embedded software and pharmaceutical-grade perfusion solutions. Because the system operates directly with transplantable organs, suppliers must meet stringent requirements for biocompatibility, sterility, reliability and traceability. Manufacturers typically retain control over core console design, organ-specific disposable circuits, software algorithms and clinical protocols, while sourcing selected pumps, sensors, plastics and electronic components from qualified medical-device supply chains.The midstream consists of specialized organ perfusion system manufacturers responsible for system integration, regulatory approval, clinical validation, disposable manufacturing and technical support. Downstream users include transplant centers and hospitals, organ procurement and recovery organizations and, to a smaller extent, academic and research institutions. The increasing integration of organ recovery, perfusion management and logistics is making the boundary between medical-device manufacturing and transplant services more complex, although product revenue remains principally driven by installed platforms and procedure-linked consumables.
Value Chain Analysis
Value creation is concentrated less in conventional hardware manufacturing than in proprietary organ-specific perfusion protocols, clinical evidence, regulatory approvals, disposable ecosystems and transplant-center integration. Reusable consoles can be sold, leased or placed to accelerate installed-base expansion, while recurring disposable perfusion sets and dedicated solutions provide a more scalable source of revenue. XVIVO explicitly identifies disposable sales rather than machines as the primary profitability driver in both its thoracic and abdominal businesses, illustrating the importance of procedure-linked recurring consumption.The highest-value platforms combine hardware, organ-specific consumables, software, clinical workflow support and logistics compatibility. Consequently, competitive advantage tends to strengthen as installed base and procedure volumes expand: more procedures create clinical data, support physician familiarity and increase recurring consumable demand. This creates relatively high switching barriers once a transplant center has established protocols, training and reimbursement processes around a particular platform.
Segment Insights
By target organ, liver represents the largest commercial segment, followed by heart and lung, while kidney NMP remains a comparatively early commercial opportunity. Liver NMP has established a particularly strong clinical proposition because viability can be assessed through multiple functional and biochemical indicators and because DCD liver transplantation has expanded rapidly. Heart perfusion represents a high-value application where transport time and DCD utilization are central considerations, while lung perfusion benefits from the established concept of ex vivo lung assessment. Kidney transplantation provides the largest procedure base but currently relies heavily on cold storage and hypothermic machine perfusion, leaving substantial room for NMP development.By application, Organ Preservation & Transplant Preparation remains the largest category. Organ Viability Assessment is increasingly embedded into NMP workflows, particularly for organs with uncertain quality. Marginal Donor Organ Recovery is a smaller but strategically important growth segment because the commercial value of NMP increasingly depends on converting previously declined organs into transplantable grafts. Other applications include research, therapeutic conditioning and emerging organ-repair approaches, but these remain less commercialized.
Downstream Market Opportunities
High-volume transplant centers remain the most attractive downstream customers because system utilization directly determines disposable consumption and economic efficiency. Centers seeking to expand transplant volumes, accept organs from greater distances or increase DCD utilization have the strongest incentive to adopt active perfusion technologies. Organ procurement and recovery organizations also represent an increasingly important channel as transplantation shifts toward centralized recovery, specialist perfusion teams and coordinated logistics.Longer term, the opportunity extends beyond preservation alone. Continuous physiological data generated during NMP may support more standardized organ acceptance decisions, treatment of donor organs outside the body and eventually data-driven or algorithm-assisted viability assessment. These capabilities could increase the value of perfusion platforms even without equivalent growth in the number of donor organs.
Regional Insights
North America remains the largest and most commercially developed market. The U.S. combines high transplant procedure volumes, established reimbursement pathways, rapid growth in DCD transplantation and broad adoption of integrated organ perfusion and procurement models. TransMedics disclosed that U.S. liver OCS penetration reached 36% and heart penetration 18% in 2025, illustrating that active perfusion has already moved beyond early clinical adoption in selected indications.Europe represents the second major technology and commercialization cluster, with established capabilities in liver, lung and abdominal organ perfusion and a growing emphasis on integrated logistics. Asia Pacific remains comparatively early in commercial adoption but presents meaningful long-term potential because of large populations, expanding transplant capabilities and increasing domestic medical-device development. China has begun developing indigenous NMP equipment, although commercial scale and installed base remain considerably below those of North America and Europe.
Competitive Landscape Analysis
The market remains highly concentrated because clinical evidence, regulatory approvals, manufacturing quality systems and transplant-center training create substantial entry barriers. Competition is not based solely on hardware specifications. The leading competitive models include portable multi-organ warm-perfusion platforms integrated with procurement and logistics, liver-focused transport-enabled NMP systems, lung-centered ex vivo perfusion platforms and multi-temperature abdominal perfusion systems capable of supporting several machine-perfusion protocols.Regional competition is structurally differentiated. North America has the deepest commercialization and integrated service infrastructure, Europe has a broader base of specialized organ preservation technologies and strong liver and lung perfusion expertise, while China is emerging from clinical translation toward domestic commercialization. Consolidation is also becoming more important: strategic acquisitions are allowing larger medical-device groups to enter organ preservation technology while providing specialized perfusion businesses with manufacturing scale, regulatory resources and international distribution. The result is likely to remain a relatively concentrated global supplier base even as procedure volumes and geographic adoption expand.
Report Scope
This report studies the global Normothermic Organ Perfusion Systems for Transplantation production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Normothermic Organ Perfusion Systems for Transplantation and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Normothermic Organ Perfusion Systems for Transplantation that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Normothermic Organ Perfusion Systems for Transplantation total production and demand, 2021-2032, (Units)
- Global Normothermic Organ Perfusion Systems for Transplantation total production value, 2021-2032, (USD Million)
- Global Normothermic Organ Perfusion Systems for Transplantation production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
- Global Normothermic Organ Perfusion Systems for Transplantation consumption by region & country, CAGR, 2021-2032 & (Units)
- U.S. VS China: Normothermic Organ Perfusion Systems for Transplantation domestic production, consumption, key domestic manufacturers and share
- Global Normothermic Organ Perfusion Systems for Transplantation production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
- Global Normothermic Organ Perfusion Systems for Transplantation production by Target Organ, production, value, CAGR, 2021-2032, (USD Million) & (Units)
- Global Normothermic Organ Perfusion Systems for Transplantation production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Normothermic Organ Perfusion Systems for Transplantation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (K US$/Unit) by manufacturer, by Target Organ, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Normothermic Organ Perfusion Systems for Transplantation Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Normothermic Organ Perfusion Systems for Transplantation Market, Segmentation by Target Organ:
- Liver
- Heart
- Lung
- Kidney
- Others
Global Normothermic Organ Perfusion Systems for Transplantation Market, Segmentation by Target Organ:
- Blood-based Perfusate
- Acellular Perfusate
- Others
Global Normothermic Organ Perfusion Systems for Transplantation Market, Segmentation by Donor Type:
- Donation after Brain Death DBD
- Donation after Circulatory Death DCD
- Others
Global Normothermic Organ Perfusion Systems for Transplantation Market, Segmentation by Application:
- Hospitals Transplant Centers
- Organ Procurement Organizations (OPOs)
- Specialty Clinics
- Research Laboratories
- Others
Companies Profiled:
- Terumo Corporation
- TransMedics Group, Inc.
- XVIVO Perfusion AB
- Aferetica S.r.l.
- Beijing TsingHan Medical Technology Co., Ltd.
- EBERS Medical Technology S.L.
Key Questions Answered
1. How big is the global Normothermic Organ Perfusion Systems for Transplantation market?2. What is the demand of the global Normothermic Organ Perfusion Systems for Transplantation market?
3. What is the year over year growth of the global Normothermic Organ Perfusion Systems for Transplantation market?
4. What is the total value of the global Normothermic Organ Perfusion Systems for Transplantation market?
5. Who are the Major Players in the global Normothermic Organ Perfusion Systems for Transplantation market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Normothermic Organ Perfusion Systems for Transplantation Introduction
1.2 World Normothermic Organ Perfusion Systems for Transplantation Supply & Forecast
1.2.1 World Normothermic Organ Perfusion Systems for Transplantation Production Value (2021 & 2025 & 2032)
1.2.2 World Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.2.3 World Normothermic Organ Perfusion Systems for Transplantation Pricing Trends (2021-2032)
1.3 World Normothermic Organ Perfusion Systems for Transplantation Production by Region (Based on Production Site)
1.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2021-2032)
1.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production by Region (2021-2032)
1.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2032)
1.3.4 North America Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.3.5 Europe Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.3.6 China Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.3.7 Japan Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Normothermic Organ Perfusion Systems for Transplantation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Normothermic Organ Perfusion Systems for Transplantation Major Market Trends
2 DEMAND SUMMARY
2.1 World Normothermic Organ Perfusion Systems for Transplantation Demand (2021-2032)
2.2 World Normothermic Organ Perfusion Systems for Transplantation Consumption by Region
2.2.1 World Normothermic Organ Perfusion Systems for Transplantation Consumption by Region (2021-2026)
2.2.2 World Normothermic Organ Perfusion Systems for Transplantation Consumption Forecast by Region (2027-2032)
2.3 United States Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.4 China Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.5 Europe Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.6 Japan Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.7 South Korea Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.8 ASEAN Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.9 India Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Manufacturer (2021-2026)
3.2 World Normothermic Organ Perfusion Systems for Transplantation Production by Manufacturer (2021-2026)
3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026)
3.4 Normothermic Organ Perfusion Systems for Transplantation Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Normothermic Organ Perfusion Systems for Transplantation Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Normothermic Organ Perfusion Systems for Transplantation in 2025
3.5.3 Global Concentration Ratios (CR8) for Normothermic Organ Perfusion Systems for Transplantation in 2025
3.6 Normothermic Organ Perfusion Systems for Transplantation Market: Overall Company Footprint Analysis
3.6.1 Normothermic Organ Perfusion Systems for Transplantation Market: Region Footprint
3.6.2 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
3.6.3 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Comparison
4.1.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Comparison
4.2.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Comparison
4.3.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value (2021-2026)
4.4.3 United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026)
4.5 China Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers and Market Share
4.5.1 China Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value (2021-2026)
4.5.3 China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026)
4.6 Rest of World Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026)
5 MARKET ANALYSIS BY TARGET ORGAN
5.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Target Organ: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Target Organ
5.2.1 Liver
5.2.2 Heart
5.2.3 Lung
5.2.4 Kidney
5.2.5 Others
5.3 Market Segment by Target Organ
5.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2032)
5.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2032)
5.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032)
6 MARKET ANALYSIS BY TARGET ORGAN
6.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Target Organ: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Organ
6.2.1 Blood-based Perfusate
6.2.2 Acellular Perfusate
6.2.3 Others
6.3 Market Segment by Target Organ
6.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2032)
6.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2032)
6.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032)
7 MARKET ANALYSIS BY DONOR TYPE
7.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Donor Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Donor Type
7.2.1 Donation after Brain Death DBD
7.2.2 Donation after Circulatory Death DCD
7.2.3 Others
7.3 Market Segment by Donor Type
7.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Donor Type (2021-2032)
7.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type (2021-2032)
7.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals Transplant Centers
8.2.2 Organ Procurement Organizations (OPOs)
8.2.3 Specialty Clinics
8.2.4 Research Laboratories
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Application (2021-2032)
8.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application (2021-2032)
8.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Terumo Corporation
9.1.1 Terumo Corporation Details
9.1.2 Terumo Corporation Major Business
9.1.3 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.1.4 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Terumo Corporation Recent Developments/Updates
9.1.6 Terumo Corporation Competitive Strengths & Weaknesses
9.2 TransMedics Group, Inc.
9.2.1 TransMedics Group, Inc. Details
9.2.2 TransMedics Group, Inc. Major Business
9.2.3 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.2.4 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 TransMedics Group, Inc. Recent Developments/Updates
9.2.6 TransMedics Group, Inc. Competitive Strengths & Weaknesses
9.3 XVIVO Perfusion AB
9.3.1 XVIVO Perfusion AB Details
9.3.2 XVIVO Perfusion AB Major Business
9.3.3 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.3.4 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 XVIVO Perfusion AB Recent Developments/Updates
9.3.6 XVIVO Perfusion AB Competitive Strengths & Weaknesses
9.4 Aferetica S.r.l.
9.4.1 Aferetica S.r.l. Details
9.4.2 Aferetica S.r.l. Major Business
9.4.3 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.4.4 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Aferetica S.r.l. Recent Developments/Updates
9.4.6 Aferetica S.r.l. Competitive Strengths & Weaknesses
9.5 Beijing TsingHan Medical Technology Co., Ltd.
9.5.1 Beijing TsingHan Medical Technology Co., Ltd. Details
9.5.2 Beijing TsingHan Medical Technology Co., Ltd. Major Business
9.5.3 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.5.4 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
9.5.6 Beijing TsingHan Medical Technology Co., Ltd. Competitive Strengths & Weaknesses
9.6 EBERS Medical Technology S.L.
9.6.1 EBERS Medical Technology S.L. Details
9.6.2 EBERS Medical Technology S.L. Major Business
9.6.3 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.6.4 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 EBERS Medical Technology S.L. Recent Developments/Updates
9.6.6 EBERS Medical Technology S.L. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Normothermic Organ Perfusion Systems for Transplantation Industry Chain
10.2 Normothermic Organ Perfusion Systems for Transplantation Upstream Analysis
10.2.1 Normothermic Organ Perfusion Systems for Transplantation Core Raw Materials
10.2.2 Main Manufacturers of Normothermic Organ Perfusion Systems for Transplantation Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Normothermic Organ Perfusion Systems for Transplantation Production Mode
10.6 Normothermic Organ Perfusion Systems for Transplantation Procurement Model
10.7 Normothermic Organ Perfusion Systems for Transplantation Industry Sales Model and Sales Channels
10.7.1 Normothermic Organ Perfusion Systems for Transplantation Sales Model
10.7.2 Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Normothermic Organ Perfusion Systems for Transplantation Introduction
1.2 World Normothermic Organ Perfusion Systems for Transplantation Supply & Forecast
1.2.1 World Normothermic Organ Perfusion Systems for Transplantation Production Value (2021 & 2025 & 2032)
1.2.2 World Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.2.3 World Normothermic Organ Perfusion Systems for Transplantation Pricing Trends (2021-2032)
1.3 World Normothermic Organ Perfusion Systems for Transplantation Production by Region (Based on Production Site)
1.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2021-2032)
1.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production by Region (2021-2032)
1.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2032)
1.3.4 North America Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.3.5 Europe Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.3.6 China Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.3.7 Japan Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Normothermic Organ Perfusion Systems for Transplantation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Normothermic Organ Perfusion Systems for Transplantation Major Market Trends
2 DEMAND SUMMARY
2.1 World Normothermic Organ Perfusion Systems for Transplantation Demand (2021-2032)
2.2 World Normothermic Organ Perfusion Systems for Transplantation Consumption by Region
2.2.1 World Normothermic Organ Perfusion Systems for Transplantation Consumption by Region (2021-2026)
2.2.2 World Normothermic Organ Perfusion Systems for Transplantation Consumption Forecast by Region (2027-2032)
2.3 United States Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.4 China Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.5 Europe Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.6 Japan Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.7 South Korea Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.8 ASEAN Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
2.9 India Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Manufacturer (2021-2026)
3.2 World Normothermic Organ Perfusion Systems for Transplantation Production by Manufacturer (2021-2026)
3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026)
3.4 Normothermic Organ Perfusion Systems for Transplantation Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Normothermic Organ Perfusion Systems for Transplantation Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Normothermic Organ Perfusion Systems for Transplantation in 2025
3.5.3 Global Concentration Ratios (CR8) for Normothermic Organ Perfusion Systems for Transplantation in 2025
3.6 Normothermic Organ Perfusion Systems for Transplantation Market: Overall Company Footprint Analysis
3.6.1 Normothermic Organ Perfusion Systems for Transplantation Market: Region Footprint
3.6.2 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
3.6.3 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Comparison
4.1.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Comparison
4.2.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Comparison
4.3.1 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value (2021-2026)
4.4.3 United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026)
4.5 China Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers and Market Share
4.5.1 China Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value (2021-2026)
4.5.3 China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026)
4.6 Rest of World Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026)
5 MARKET ANALYSIS BY TARGET ORGAN
5.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Target Organ: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Target Organ
5.2.1 Liver
5.2.2 Heart
5.2.3 Lung
5.2.4 Kidney
5.2.5 Others
5.3 Market Segment by Target Organ
5.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2032)
5.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2032)
5.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032)
6 MARKET ANALYSIS BY TARGET ORGAN
6.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Target Organ: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Organ
6.2.1 Blood-based Perfusate
6.2.2 Acellular Perfusate
6.2.3 Others
6.3 Market Segment by Target Organ
6.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2032)
6.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2032)
6.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032)
7 MARKET ANALYSIS BY DONOR TYPE
7.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Donor Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Donor Type
7.2.1 Donation after Brain Death DBD
7.2.2 Donation after Circulatory Death DCD
7.2.3 Others
7.3 Market Segment by Donor Type
7.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Donor Type (2021-2032)
7.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type (2021-2032)
7.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Normothermic Organ Perfusion Systems for Transplantation Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals Transplant Centers
8.2.2 Organ Procurement Organizations (OPOs)
8.2.3 Specialty Clinics
8.2.4 Research Laboratories
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Normothermic Organ Perfusion Systems for Transplantation Production by Application (2021-2032)
8.3.2 World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application (2021-2032)
8.3.3 World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Terumo Corporation
9.1.1 Terumo Corporation Details
9.1.2 Terumo Corporation Major Business
9.1.3 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.1.4 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Terumo Corporation Recent Developments/Updates
9.1.6 Terumo Corporation Competitive Strengths & Weaknesses
9.2 TransMedics Group, Inc.
9.2.1 TransMedics Group, Inc. Details
9.2.2 TransMedics Group, Inc. Major Business
9.2.3 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.2.4 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 TransMedics Group, Inc. Recent Developments/Updates
9.2.6 TransMedics Group, Inc. Competitive Strengths & Weaknesses
9.3 XVIVO Perfusion AB
9.3.1 XVIVO Perfusion AB Details
9.3.2 XVIVO Perfusion AB Major Business
9.3.3 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.3.4 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 XVIVO Perfusion AB Recent Developments/Updates
9.3.6 XVIVO Perfusion AB Competitive Strengths & Weaknesses
9.4 Aferetica S.r.l.
9.4.1 Aferetica S.r.l. Details
9.4.2 Aferetica S.r.l. Major Business
9.4.3 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.4.4 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Aferetica S.r.l. Recent Developments/Updates
9.4.6 Aferetica S.r.l. Competitive Strengths & Weaknesses
9.5 Beijing TsingHan Medical Technology Co., Ltd.
9.5.1 Beijing TsingHan Medical Technology Co., Ltd. Details
9.5.2 Beijing TsingHan Medical Technology Co., Ltd. Major Business
9.5.3 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.5.4 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
9.5.6 Beijing TsingHan Medical Technology Co., Ltd. Competitive Strengths & Weaknesses
9.6 EBERS Medical Technology S.L.
9.6.1 EBERS Medical Technology S.L. Details
9.6.2 EBERS Medical Technology S.L. Major Business
9.6.3 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
9.6.4 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 EBERS Medical Technology S.L. Recent Developments/Updates
9.6.6 EBERS Medical Technology S.L. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Normothermic Organ Perfusion Systems for Transplantation Industry Chain
10.2 Normothermic Organ Perfusion Systems for Transplantation Upstream Analysis
10.2.1 Normothermic Organ Perfusion Systems for Transplantation Core Raw Materials
10.2.2 Main Manufacturers of Normothermic Organ Perfusion Systems for Transplantation Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Normothermic Organ Perfusion Systems for Transplantation Production Mode
10.6 Normothermic Organ Perfusion Systems for Transplantation Procurement Model
10.7 Normothermic Organ Perfusion Systems for Transplantation Industry Sales Model and Sales Channels
10.7.1 Normothermic Organ Perfusion Systems for Transplantation Sales Model
10.7.2 Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2021-2026) & (USD Million)
Table 3. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2027-2032) & (USD Million)
Table 4. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Region (2021-2026)
Table 5. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Region (2027-2032)
Table 6. World Normothermic Organ Perfusion Systems for Transplantation Production by Region (2021-2026) & (Units)
Table 7. World Normothermic Organ Perfusion Systems for Transplantation Production by Region (2027-2032) & (Units)
Table 8. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Region (2021-2026)
Table 9. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Region (2027-2032)
Table 10. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2026) & (K US$/Unit)
Table 11. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2027-2032) & (K US$/Unit)
Table 12. Normothermic Organ Perfusion Systems for Transplantation Major Market Trends
Table 13. World Normothermic Organ Perfusion Systems for Transplantation Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Normothermic Organ Perfusion Systems for Transplantation Consumption by Region (2021-2026) & (Units)
Table 15. World Normothermic Organ Perfusion Systems for Transplantation Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Normothermic Organ Perfusion Systems for Transplantation Producers in 2025
Table 18. World Normothermic Organ Perfusion Systems for Transplantation Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Normothermic Organ Perfusion Systems for Transplantation Producers in 2025
Table 20. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 21. Global Normothermic Organ Perfusion Systems for Transplantation Company Evaluation Quadrant
Table 22. World Normothermic Organ Perfusion Systems for Transplantation Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Normothermic Organ Perfusion Systems for Transplantation Production Site of Key Manufacturer
Table 24. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
Table 25. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
Table 26. Normothermic Organ Perfusion Systems for Transplantation Competitive Factors
Table 27. Normothermic Organ Perfusion Systems for Transplantation New Entrant and Capacity Expansion Plans
Table 28. Normothermic Organ Perfusion Systems for Transplantation Mergers & Acquisitions Activity
Table 29. United States VS China Normothermic Organ Perfusion Systems for Transplantation Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Normothermic Organ Perfusion Systems for Transplantation Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Normothermic Organ Perfusion Systems for Transplantation Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share (2021-2026)
Table 37. China Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share (2021-2026)
Table 42. Rest of World Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share (2021-2026)
Table 47. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 48. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2026) & (Units)
Table 49. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2027-2032) & (Units)
Table 50. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2026) & (USD Million)
Table 51. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2027-2032) & (USD Million)
Table 52. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2026) & (K US$/Unit)
Table 53. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2027-2032) & (K US$/Unit)
Table 54. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 55. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2026) & (Units)
Table 56. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2027-2032) & (Units)
Table 57. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2026) & (USD Million)
Table 58. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2027-2032) & (USD Million)
Table 59. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2026) & (K US$/Unit)
Table 60. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2027-2032) & (K US$/Unit)
Table 61. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Normothermic Organ Perfusion Systems for Transplantation Production by Donor Type (2021-2026) & (Units)
Table 63. World Normothermic Organ Perfusion Systems for Transplantation Production by Donor Type (2027-2032) & (Units)
Table 64. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type (2021-2026) & (USD Million)
Table 65. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type (2027-2032) & (USD Million)
Table 66. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2021-2026) & (K US$/Unit)
Table 67. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2027-2032) & (K US$/Unit)
Table 68. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Normothermic Organ Perfusion Systems for Transplantation Production by Application (2021-2026) & (Units)
Table 70. World Normothermic Organ Perfusion Systems for Transplantation Production by Application (2027-2032) & (Units)
Table 71. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application (2021-2026) & (USD Million)
Table 72. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application (2027-2032) & (USD Million)
Table 73. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2026) & (K US$/Unit)
Table 74. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2027-2032) & (K US$/Unit)
Table 75. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 76. Terumo Corporation Major Business
Table 77. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 78. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Terumo Corporation Recent Developments/Updates
Table 80. Terumo Corporation Competitive Strengths & Weaknesses
Table 81. TransMedics Group, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. TransMedics Group, Inc. Major Business
Table 83. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 84. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. TransMedics Group, Inc. Recent Developments/Updates
Table 86. TransMedics Group, Inc. Competitive Strengths & Weaknesses
Table 87. XVIVO Perfusion AB Basic Information, Manufacturing Base and Competitors
Table 88. XVIVO Perfusion AB Major Business
Table 89. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 90. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. XVIVO Perfusion AB Recent Developments/Updates
Table 92. XVIVO Perfusion AB Competitive Strengths & Weaknesses
Table 93. Aferetica S.r.l. Basic Information, Manufacturing Base and Competitors
Table 94. Aferetica S.r.l. Major Business
Table 95. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 96. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Aferetica S.r.l. Recent Developments/Updates
Table 98. Aferetica S.r.l. Competitive Strengths & Weaknesses
Table 99. Beijing TsingHan Medical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 100. Beijing TsingHan Medical Technology Co., Ltd. Major Business
Table 101. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 102. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
Table 104. Beijing TsingHan Medical Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 105. EBERS Medical Technology S.L. Basic Information, Manufacturing Base and Competitors
Table 106. EBERS Medical Technology S.L. Major Business
Table 107. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 108. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. EBERS Medical Technology S.L. Recent Developments/Updates
Table 110. EBERS Medical Technology S.L. Competitive Strengths & Weaknesses
Table 111. Global Key Players of Normothermic Organ Perfusion Systems for Transplantation Upstream (Raw Materials)
Table 112. Global Normothermic Organ Perfusion Systems for Transplantation Typical Customers
Table 113. Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
Table 1. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2021-2026) & (USD Million)
Table 3. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Region (2027-2032) & (USD Million)
Table 4. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Region (2021-2026)
Table 5. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Region (2027-2032)
Table 6. World Normothermic Organ Perfusion Systems for Transplantation Production by Region (2021-2026) & (Units)
Table 7. World Normothermic Organ Perfusion Systems for Transplantation Production by Region (2027-2032) & (Units)
Table 8. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Region (2021-2026)
Table 9. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Region (2027-2032)
Table 10. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2026) & (K US$/Unit)
Table 11. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2027-2032) & (K US$/Unit)
Table 12. Normothermic Organ Perfusion Systems for Transplantation Major Market Trends
Table 13. World Normothermic Organ Perfusion Systems for Transplantation Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Normothermic Organ Perfusion Systems for Transplantation Consumption by Region (2021-2026) & (Units)
Table 15. World Normothermic Organ Perfusion Systems for Transplantation Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Normothermic Organ Perfusion Systems for Transplantation Producers in 2025
Table 18. World Normothermic Organ Perfusion Systems for Transplantation Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Normothermic Organ Perfusion Systems for Transplantation Producers in 2025
Table 20. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 21. Global Normothermic Organ Perfusion Systems for Transplantation Company Evaluation Quadrant
Table 22. World Normothermic Organ Perfusion Systems for Transplantation Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Normothermic Organ Perfusion Systems for Transplantation Production Site of Key Manufacturer
Table 24. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
Table 25. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
Table 26. Normothermic Organ Perfusion Systems for Transplantation Competitive Factors
Table 27. Normothermic Organ Perfusion Systems for Transplantation New Entrant and Capacity Expansion Plans
Table 28. Normothermic Organ Perfusion Systems for Transplantation Mergers & Acquisitions Activity
Table 29. United States VS China Normothermic Organ Perfusion Systems for Transplantation Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Normothermic Organ Perfusion Systems for Transplantation Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Normothermic Organ Perfusion Systems for Transplantation Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share (2021-2026)
Table 37. China Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share (2021-2026)
Table 42. Rest of World Based Normothermic Organ Perfusion Systems for Transplantation Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share (2021-2026)
Table 47. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 48. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2026) & (Units)
Table 49. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2027-2032) & (Units)
Table 50. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2026) & (USD Million)
Table 51. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2027-2032) & (USD Million)
Table 52. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2026) & (K US$/Unit)
Table 53. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2027-2032) & (K US$/Unit)
Table 54. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 55. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2021-2026) & (Units)
Table 56. World Normothermic Organ Perfusion Systems for Transplantation Production by Target Organ (2027-2032) & (Units)
Table 57. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2021-2026) & (USD Million)
Table 58. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ (2027-2032) & (USD Million)
Table 59. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2026) & (K US$/Unit)
Table 60. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2027-2032) & (K US$/Unit)
Table 61. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Normothermic Organ Perfusion Systems for Transplantation Production by Donor Type (2021-2026) & (Units)
Table 63. World Normothermic Organ Perfusion Systems for Transplantation Production by Donor Type (2027-2032) & (Units)
Table 64. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type (2021-2026) & (USD Million)
Table 65. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type (2027-2032) & (USD Million)
Table 66. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2021-2026) & (K US$/Unit)
Table 67. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2027-2032) & (K US$/Unit)
Table 68. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Normothermic Organ Perfusion Systems for Transplantation Production by Application (2021-2026) & (Units)
Table 70. World Normothermic Organ Perfusion Systems for Transplantation Production by Application (2027-2032) & (Units)
Table 71. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application (2021-2026) & (USD Million)
Table 72. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application (2027-2032) & (USD Million)
Table 73. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2026) & (K US$/Unit)
Table 74. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2027-2032) & (K US$/Unit)
Table 75. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 76. Terumo Corporation Major Business
Table 77. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 78. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Terumo Corporation Recent Developments/Updates
Table 80. Terumo Corporation Competitive Strengths & Weaknesses
Table 81. TransMedics Group, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. TransMedics Group, Inc. Major Business
Table 83. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 84. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. TransMedics Group, Inc. Recent Developments/Updates
Table 86. TransMedics Group, Inc. Competitive Strengths & Weaknesses
Table 87. XVIVO Perfusion AB Basic Information, Manufacturing Base and Competitors
Table 88. XVIVO Perfusion AB Major Business
Table 89. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 90. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. XVIVO Perfusion AB Recent Developments/Updates
Table 92. XVIVO Perfusion AB Competitive Strengths & Weaknesses
Table 93. Aferetica S.r.l. Basic Information, Manufacturing Base and Competitors
Table 94. Aferetica S.r.l. Major Business
Table 95. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 96. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Aferetica S.r.l. Recent Developments/Updates
Table 98. Aferetica S.r.l. Competitive Strengths & Weaknesses
Table 99. Beijing TsingHan Medical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 100. Beijing TsingHan Medical Technology Co., Ltd. Major Business
Table 101. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 102. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
Table 104. Beijing TsingHan Medical Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 105. EBERS Medical Technology S.L. Basic Information, Manufacturing Base and Competitors
Table 106. EBERS Medical Technology S.L. Major Business
Table 107. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 108. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Production (Units), Price (K US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. EBERS Medical Technology S.L. Recent Developments/Updates
Table 110. EBERS Medical Technology S.L. Competitive Strengths & Weaknesses
Table 111. Global Key Players of Normothermic Organ Perfusion Systems for Transplantation Upstream (Raw Materials)
Table 112. Global Normothermic Organ Perfusion Systems for Transplantation Typical Customers
Table 113. Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
LIST OF FIGURES
Figure 1. Normothermic Organ Perfusion Systems for Transplantation Picture
Figure 2. World Normothermic Organ Perfusion Systems for Transplantation Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Normothermic Organ Perfusion Systems for Transplantation Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 5. World Normothermic Organ Perfusion Systems for Transplantation Average Price (2021-2032) & (K US$/Unit)
Figure 6. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Region (2021-2032)
Figure 7. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Region (2021-2032)
Figure 8. North America Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 9. Europe Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 10. China Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 11. Japan Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 12. Normothermic Organ Perfusion Systems for Transplantation Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 15. World Normothermic Organ Perfusion Systems for Transplantation Consumption Market Share by Region (2021-2032)
Figure 16. United States Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 17. China Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 18. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 19. Japan Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 20. South Korea Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 21. ASEAN Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 22. India Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Normothermic Organ Perfusion Systems for Transplantation by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Normothermic Organ Perfusion Systems for Transplantation Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Normothermic Organ Perfusion Systems for Transplantation Markets in 2025
Figure 26. United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share 2025
Figure 30. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share 2025
Figure 32. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 33. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ in 2025
Figure 34. Liver
Figure 35. Heart
Figure 36. Lung
Figure 37. Kidney
Figure 38. Others
Figure 39. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Target Organ (2021-2032)
Figure 40. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ (2021-2032)
Figure 41. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032) & (K US$/Unit)
Figure 42. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 43. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ in 2025
Figure 44. Blood-based Perfusate
Figure 45. Acellular Perfusate
Figure 46. Others
Figure 47. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Target Organ (2021-2032)
Figure 48. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ (2021-2032)
Figure 49. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032) & (K US$/Unit)
Figure 50. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type, (USD Million), 2021 & 2025 & 2032
Figure 51. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Donor Type in 2025
Figure 52. Donation after Brain Death DBD
Figure 53. Donation after Circulatory Death DCD
Figure 54. Others
Figure 55. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Donor Type (2021-2032)
Figure 56. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Donor Type (2021-2032)
Figure 57. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2021-2032) & (K US$/Unit)
Figure 58. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Application in 2025
Figure 60. Hospitals Transplant Centers
Figure 61. Organ Procurement Organizations (OPOs)
Figure 62. Specialty Clinics
Figure 63. Research Laboratories
Figure 64. Others
Figure 65. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Application (2021-2032)
Figure 66. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Application (2021-2032)
Figure 67. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032) & (K US$/Unit)
Figure 68. Normothermic Organ Perfusion Systems for Transplantation Industry Chain
Figure 69. Normothermic Organ Perfusion Systems for Transplantation Procurement Model
Figure 70. Normothermic Organ Perfusion Systems for Transplantation Sales Model
Figure 71. Normothermic Organ Perfusion Systems for Transplantation Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Normothermic Organ Perfusion Systems for Transplantation Picture
Figure 2. World Normothermic Organ Perfusion Systems for Transplantation Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Normothermic Organ Perfusion Systems for Transplantation Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 5. World Normothermic Organ Perfusion Systems for Transplantation Average Price (2021-2032) & (K US$/Unit)
Figure 6. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Region (2021-2032)
Figure 7. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Region (2021-2032)
Figure 8. North America Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 9. Europe Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 10. China Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 11. Japan Normothermic Organ Perfusion Systems for Transplantation Production (2021-2032) & (Units)
Figure 12. Normothermic Organ Perfusion Systems for Transplantation Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 15. World Normothermic Organ Perfusion Systems for Transplantation Consumption Market Share by Region (2021-2032)
Figure 16. United States Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 17. China Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 18. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 19. Japan Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 20. South Korea Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 21. ASEAN Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 22. India Normothermic Organ Perfusion Systems for Transplantation Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Normothermic Organ Perfusion Systems for Transplantation by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Normothermic Organ Perfusion Systems for Transplantation Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Normothermic Organ Perfusion Systems for Transplantation Markets in 2025
Figure 26. United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Normothermic Organ Perfusion Systems for Transplantation Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Normothermic Organ Perfusion Systems for Transplantation Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share 2025
Figure 30. China Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Normothermic Organ Perfusion Systems for Transplantation Production Market Share 2025
Figure 32. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 33. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ in 2025
Figure 34. Liver
Figure 35. Heart
Figure 36. Lung
Figure 37. Kidney
Figure 38. Others
Figure 39. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Target Organ (2021-2032)
Figure 40. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ (2021-2032)
Figure 41. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032) & (K US$/Unit)
Figure 42. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 43. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ in 2025
Figure 44. Blood-based Perfusate
Figure 45. Acellular Perfusate
Figure 46. Others
Figure 47. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Target Organ (2021-2032)
Figure 48. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Target Organ (2021-2032)
Figure 49. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032) & (K US$/Unit)
Figure 50. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Donor Type, (USD Million), 2021 & 2025 & 2032
Figure 51. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Donor Type in 2025
Figure 52. Donation after Brain Death DBD
Figure 53. Donation after Circulatory Death DCD
Figure 54. Others
Figure 55. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Donor Type (2021-2032)
Figure 56. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Donor Type (2021-2032)
Figure 57. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Donor Type (2021-2032) & (K US$/Unit)
Figure 58. World Normothermic Organ Perfusion Systems for Transplantation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Application in 2025
Figure 60. Hospitals Transplant Centers
Figure 61. Organ Procurement Organizations (OPOs)
Figure 62. Specialty Clinics
Figure 63. Research Laboratories
Figure 64. Others
Figure 65. World Normothermic Organ Perfusion Systems for Transplantation Production Market Share by Application (2021-2032)
Figure 66. World Normothermic Organ Perfusion Systems for Transplantation Production Value Market Share by Application (2021-2032)
Figure 67. World Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032) & (K US$/Unit)
Figure 68. Normothermic Organ Perfusion Systems for Transplantation Industry Chain
Figure 69. Normothermic Organ Perfusion Systems for Transplantation Procurement Model
Figure 70. Normothermic Organ Perfusion Systems for Transplantation Sales Model
Figure 71. Normothermic Organ Perfusion Systems for Transplantation Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
